This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Teva Pharmaceutical Industries Ltd (TEVA)

NYSE: Health Care

Company Cash Flow
Dec 2014 Dec 2013 Dec 2012 Dec 2011
Cash Flow From Operating Activities
Net Income (Loss) 3.04B 1.25B 1.91B 2.77B
Operating Gains/Losses 1.00M 18.00M -3.00M -207.00M
Extraordinary Gains / Losses 0.00 0.00 0.00 0.00
(Increase) Decrease In Receivables 710.00M 85.00M 936.00M 704.00M
(Increase) Decrease in Inventories 230.00M 399.00M -449.00M -410.00M
(Increase) Decrease In Other Current Assets -36.00M 106.00M -54.00M -240.00M
(Decrease) Increase In Payables -614.00M 378.00M -19.00M 543.00M
(Decrease) Increase In Other Current Liabilities 0.00 0.00 0.00 0.00
(Increase) Decrease In Other Working Capital 0.00 0.00 0.00 0.00
Other Non-Cash Items 512.00M 736.00M 1.23B 407.00M
Net Cash From Continuing Operations 5.13B 3.24B 4.57B 4.13B
Net Cash From Discontinued Operations 0.00 0.00 0.00 0.00
Cash Provided By Investing Activities
Net Cash From Total Operating Activities 5.13B 3.24B 4.57B 4.13B
Sale of Property, Plant & Equipment 196.00M 187.00M 264.00M 279.00M
Cash Used for Investing Activities
Sale of Short-Term Investments 0.00 0.00 0.00 0.00
Purchases of Property, Plant & Equipment -929.00M -1.03B -1.10B -1.05B
Acquisitions -363.00M -39.00M 0.00 -6.56B
Purchases of Short-Term Investments 0.00 0.00 0.00 0.00
Other Cash from Investing Activities -30.00M -104.00M -93.00M -49.00M
Cash Provided by Financing Activities
Net Cash From Investing Activities -1.45B -1.15B -1.13B -7.60B
Issuance of Debt 0.00 338.00M 1.24B 6.72B
Cash Used for Financing Activities
Issuance of Capital Stock 514.00M 91.00M 14.00M 71.00M
Repayment of Long-Term Debt -839.00M -3.13B -2.21B -1.56B
Repurchase of Capital Stock -500.00M -497.00M -1.16B -899.00M
Payment of Cash Dividends -1.16B -1.09B -855.00M -800.00M
Other Financing Charges, Net -394.00M 407.00M 1.30B -194.00M
Net Cash From Financing Activities -2.38B -3.88B -1.68B 3.34B
Effect of Exchange Rate Changes -114.00M -48.00M 23.00M -21.00M
Net Change in Cash & Cash Equivalents 1.19B -1.84B 1.78B -152.00M

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free

TEVA Teva Pharmaceutical Industries Ltd

Chart of TEVA

Analysts Ratings for TEVA

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 11 11 12 10
Moderate Buy 2 2 2 2
Hold 4 4 4 4
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 1

TEVA Chatter

Top Rated Stocks Top Rated Funds Top Rated ETFs